Skip to content
★ Sign in to follow
AM

Alexander M. Milstein

Total declarations
4
Company
1
▲ Purchases (4 ops.)
€4,632
▼ Sales (0 ops.)
—

Latest filing published 11 Sept 2006 for CERENOME, INC., €710.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4
Positive at T+90
100%
Median T+90
+2.2%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Alexander M. Milstein: trading record in brief

Alexander M. Milstein appears in our data through filings on Cerenome, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 1 September 2006 to 8 September 2006.

On the market, this insider has only ever bought: 4 purchases, €4,632 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The median purchase comes to €1,151. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +2.2%. This is a record of the past, not a forecast.

On 11 September 2006 came the latest disclosure, an open-market purchase for €710 in Cerenome, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Alexander M. Milstein

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    Vice President Clinical DeveloExecutivesCerenome, Inc.
    900 USD0SEC
    200 shares@ US$4.50Common StockSEC:0001327916-06-000003:0
    Canonical exit: 6 Dec 2006 (T+90)
  • ▲
    Vice President Clinical DeveloExecutivesCerenome, Inc.
    900 USD0SEC
    200 shares@ US$4.50Common StockSEC:0001327916-06-000003:1
    Canonical exit: 7 Dec 2006 (T+90)
  • ▲
    Vice President Clinical DevelExecutivesCerenome, Inc.
    2,080 USD0SEC
    400 shares@ US$5.20Common StockSEC:0001327916-06-000002:0
    Canonical exit: 30 Nov 2006 (T+90)
  • ▲
    Vice President Clinical DevelExecutivesCerenome, Inc.
    2,040 USD0SEC
    400 shares@ US$5.10Common StockSEC:0001327916-06-000002:1
    Canonical exit: 4 Dec 2006 (T+90)

4 of 4 declarations